These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86. Germline BRCA Mutations in a Large Clinic-Based Cohort of Patients With Pancreatic Adenocarcinoma. Holter S; Borgida A; Dodd A; Grant R; Semotiuk K; Hedley D; Dhani N; Narod S; Akbari M; Moore M; Gallinger S J Clin Oncol; 2015 Oct; 33(28):3124-9. PubMed ID: 25940717 [TBL] [Abstract][Full Text] [Related]
87. Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers. Cullinane CA; Lubinski J; Neuhausen SL; Ghadirian P; Lynch HT; Isaacs C; Weber B; Moller P; Offit K; Kim-Sing C; Friedman E; Randall S; Pasini B; Ainsworth P; Gershoni-Baruch R; Foulkes WD; Klijn J; Tung N; Rennert G; Olopade O; Couch F; Wagner T; Olsson H; Sun P; Weitzel JN; Narod SA Int J Cancer; 2005 Dec; 117(6):988-91. PubMed ID: 15986445 [TBL] [Abstract][Full Text] [Related]
88. Two BRCA1/2 founder mutations in Jews of Sephardic origin. Sagi M; Eilat A; Ben Avi L; Goldberg Y; Bercovich D; Hamburger T; Peretz T; Lerer I Fam Cancer; 2011 Mar; 10(1):59-63. PubMed ID: 21063910 [TBL] [Abstract][Full Text] [Related]
89. Prevalence and characterization of BRCA1 and BRCA2 germline mutations in Chinese women with familial breast cancer. Zhang J; Pei R; Pang Z; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Xie Y Breast Cancer Res Treat; 2012 Apr; 132(2):421-8. PubMed ID: 21614564 [TBL] [Abstract][Full Text] [Related]
90. Prophylactic mastectomy in BRCA1/2 mutation carriers and women at risk of hereditary breast cancer: long-term experiences at the Rotterdam Family Cancer Clinic. Heemskerk-Gerritsen BA; Brekelmans CT; Menke-Pluymers MB; van Geel AN; Tilanus-Linthorst MM; Bartels CC; Tan M; Meijers-Heijboer HE; Klijn JG; Seynaeve C Ann Surg Oncol; 2007 Dec; 14(12):3335-44. PubMed ID: 17541692 [TBL] [Abstract][Full Text] [Related]
91. Family history predictors of BRCA1/BRCA2 mutation status among Tunisian breast/ovarian cancer families. Riahi A; Ghourabi ME; Fourati A; Chaabouni-Bouhamed H Breast Cancer; 2017 Mar; 24(2):238-244. PubMed ID: 27025497 [TBL] [Abstract][Full Text] [Related]
92. Survival after breast cancer in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers. Lee JS; Wacholder S; Struewing JP; McAdams M; Pee D; Brody LC; Tucker MA; Hartge P J Natl Cancer Inst; 1999 Feb; 91(3):259-63. PubMed ID: 10037104 [TBL] [Abstract][Full Text] [Related]
93. The risk of breast cancer in BRCA1 and BRCA2 mutation carriers without a first-degree relative with breast cancer. Metcalfe KA; Lubinski J; Gronwald J; Huzarski T; McCuaig J; Lynch HT; Karlan B; Foulkes WD; Singer CF; Neuhausen SL; Senter L; Eisen A; Sun P; Narod SA; Clin Genet; 2018 May; 93(5):1063-1068. PubMed ID: 29206279 [TBL] [Abstract][Full Text] [Related]
94. Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysis. Moorman PG; Iversen ES; Marcom PK; Marks JR; Wang F; ; Lee E; Ursin G; Rebbeck TR; Domchek SM; Arun B; Susswein L; Isaacs C; Garber JE; Visvanathan K; Griffin CA; Sutphen R; Brzosowicz J; Gruber S; Finkelstein DM; Schildkraut JM Breast Cancer Res Treat; 2010 Nov; 124(2):441-51. PubMed ID: 20309627 [TBL] [Abstract][Full Text] [Related]
95. Prevalence and Penetrance of BRCA1 and BRCA2 Germline Mutations in Colombian Breast Cancer Patients. Torres D; Bermejo JL; Rashid MU; Briceño I; Gil F; Beltran A; Ariza V; Hamann U Sci Rep; 2017 Jul; 7(1):4713. PubMed ID: 28680148 [TBL] [Abstract][Full Text] [Related]
96. The association between cancer family history and ovarian cancer risk in BRCA1/2 mutation carriers: can it be explained by the mutation position? Teixeira N; van der Hout A; Oosterwijk JC; Vos JR; ; Devilee P; van Engelen K; Meijers-Heijboer H; van der Luijt RB; Kriege M; Mensenkamp AR; Rookus MA; van Roozendaal KE; Mourits MJE; de Bock GH Eur J Hum Genet; 2018 Jun; 26(6):848-857. PubMed ID: 29483665 [TBL] [Abstract][Full Text] [Related]
97. Anti-Müllerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations. Phillips KA; Collins IM; Milne RL; McLachlan SA; Friedlander M; Hickey M; Stern C; Hopper JL; Fisher R; Kannemeyer G; Picken S; Smith CD; Kelsey TW; Anderson RA; Hum Reprod; 2016 May; 31(5):1126-32. PubMed ID: 27094481 [TBL] [Abstract][Full Text] [Related]
98. A novel BRCA-1 mutation in Arab kindred from east Jerusalem with breast and ovarian cancer. Kadouri L; Bercovich D; Elimelech A; Lerer I; Sagi M; Glusman G; Shochat C; Korem S; Hamburger T; Nissan A; Abu-Halaf N; Badrriyah M; Abeliovich D; Peretz T BMC Cancer; 2007 Jan; 7():14. PubMed ID: 17233897 [TBL] [Abstract][Full Text] [Related]